Advertisement
Loading...

Bausch Health Companies Inc.

BHC•NYSE
Healthcare
Drug Manufacturers - Specialty & Generic
$5.42
$-0.03(-0.55%)
U.S. Market opens in 28h 26m

Bausch Health Companies Inc. (BHC) Stock Overview

Explore Bausch Health Companies Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap2B
P/E Ratio-1.70
EPS (TTM)$-3.24
ROE1.21%
Fundamental Analysis

AI Price Forecasts

1 Month$4.14
3 Months$3.50
1 Year Target$6.82

BHC Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Bausch Health Companies Inc. (BHC) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 45.24, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $6.82.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -1.70 and a market capitalization of 2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.37%
5-Day Change
-4.74%
1-Month Change
-5.40%
3-Month Change
-9.35%
6-Month Change
-13.54%
Year-to-Date (YTD) Change
-21.87%
1-Year Change
18.04%
3-Year Change
-9.95%
5-Year Change
-81.44%
All-Time (Max) Change
986.00%

Contact Information

https://www.bauschhealth.com
15147446792
2150 St. ElzEar Boulevard West, Laval, QC, H7L 4A8

Company Facts

20,700 Employees
IPO DateMar 29, 1994
CountryCA
Actively Trading

Frequently Asked Questions